A Phase 2 interventional study of Telerehabilitation and Paper-based exercise in Multiple Sclerosis, sponsored by Danish Multiple Sclerosis Hospitals. Not yet recruiting at 5 sites in 4 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-12-30.
Sponsored by Danish Multiple Sclerosis Hospitals · Phase 2, Interventional, and Treatment
The overall purpose of the present study is to investigate the effect of an advanced telerehablitation system (TRS) in persons with multiple sclerosis on mobility. The advanced telerhabilitation system is based on AI components, and delivers instant feedback to the partcipants. If the project is successful, it can help optimize exercise for those persons with multiple sclerosis who are either not able or willing to travel to a clinical setting for exericse.
3,460 studies on the registry are indexed under Multiple Sclerosis; 661 are open to participants now.
This study's planned enrollment of 94 is above the median of 50 across 2,342 interventional studies indexed under Multiple Sclerosis.
Browse Multiple Sclerosis studies →This is the only study on the registry with Danish Multiple Sclerosis Hospitals as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
10 weeks of home-based exercise performed with the telerehabilitation system. Partipicants will perform two sessions per week (30-45 minutes). The content of the exercise program and the specific exercises will be planned by specialized physiotherapists.
Behavioral: Telerehabilitation
10 weeks of home-based exercise with paper-based instructions. Partipicants will perform two sessions per week (30-45 minutes). The content of the exercise program and the specific exercises will be planned by specialized physiotherapists.Paper-based exercise instructions
Behavioral: Paper-based exercise
Advanced telerehabilitation with a program made by specialized physiotherapists and delivered through the WizeCare system.
Paper-based exercise instructions made by specialized physiotherapists.
30 second sit to stand test
Measure of lower extremity muscle power and a proxy measure of mobility
Time frame: Baseline to 10 weeks
Short Physical Performance Battery
Meaure of balance, walking function and lower extremity muscle strength
Time frame: Baseline to 10 weeks
Functional Reach Test
A measure of stability
Time frame: Baseline to 10 weeks
Timed 25 feet foot walk test
A measure of walking speed
Time frame: Baseline to 10 weeks
MiniBESTest
A measure of balance
Time frame: Baseline to 10 weeks
Six minute walk test
A measure of walking endurance
Time frame: Baseline to 10 weeks
Modified Fatigue Impact Scale
Patient-reported measure of fatigue
Time frame: Baseline
12 item Multiple Sclerosis Walking Scale
Patient-reported outcome of walking function
Time frame: Baseline to 10 weeks
Multiple Sclerosis Impact Scale
Patient-reported measure on the impact of multiple sclerosis
Time frame: Baseline to 10 weeks
EQ-5D-5L
Patient-reported measure of quality of life
Time frame: Baseline to 10 weeks
State-Trait Anxiety Inventory
Patient-reported measure of anxiety
Time frame: Baseline to 10 weeks
Quick Inventory of Depression Symptomology
Patient-reported measure of depressive symptoms
Time frame: Baseline to 10 weeks
Client Services Receipt Inventory
Patient-reported measure of used health services
Time frame: Baseline to 10 weeks
Digital Health Literacy Scale
Patient-reported measure of digital health literacy
Time frame: Baseline
Telehealth Usability Questionnaire
Patient-reported measure of telehealth usability
Time frame: 10 weeks
Semi-structed interview
A semi-structured interview on the satisfaction with the telerehabilitation system
Time frame: 10 weeks
Plan to share: Undecided
No publications or documents are linked to this record.
This study is not yet recruiting, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.